Galibier Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Galibier Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.18M	Hold	2,432	–	–	0.39%	24
2025 Q2	$986K	Buy	2,432 +950	+64%	+$397K	0.3%	27
2025 Q1	$737K	Sell	1,482 -119	-7%	-$64.5K	0.23%	27
2024 Q4	$833K	Hold	1,601	–	–	0.24%	25
2024 Q3	$990K	Hold	1,601	–	–	0.22%	32
2024 Q2	$885K	Hold	1,601	–	–	0.22%	34
2024 Q1	$931K	Hold	1,601	–	–	0.22%	30
2023 Q4	$850K	Hold	1,601	–	–	0.22%	26
2023 Q3	$810K	Sell	1,601 -64	-4%	-$34.1K	0.18%	28
2023 Q2	$869K	Hold	1,665	–	–	0.2%	29
2023 Q1	$960K	Hold	1,665	–	–	0.23%	29
2022 Q4	$917K	Hold	1,665	–	–	0.19%	28
2022 Q3	$844K	Hold	1,665	–	–	0.17%	31
2022 Q2	$905K	Hold	1,665	–	–	0.17%	30
2022 Q1	$983K	Hold	1,665	–	–	0.13%	31
2021 Q4	$1.11M	Hold	1,665	–	–	0.16%	27
2021 Q3	$951K	Sell	1,665 -500	-23%	-$274K	0.13%	31
2021 Q2	$1.09M	Hold	2,165	–	–	0.15%	29
2021 Q1	$988K	Hold	2,165	–	–	0.15%	31
2020 Q4	$1.01M	Sell	2,165 -230	-10%	-$108K	0.17%	26
2020 Q3	$1.06M	Sell	2,395 -450	-16%	-$186K	0.25%	25
2020 Q2	$1.03M	Hold	2,845	–	–	0.33%	23
2020 Q1	$807K	Buy	2,845 +260	+10%	+$82K	0.35%	24
2019 Q4	$840K	Hold	2,585	–	–	0.27%	30
2019 Q3	$753K	Hold	2,585	–	–	0.3%	30
2019 Q2	$759K	Hold	2,585	–	–	0.35%	30
2019 Q1	$708K	Sell	2,585 -510	-16%	-$127K	0.42%	30
2018 Q4	$693K	Buy	+3,095	New	+$726K	0.47%	29

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Galibier Capital Management's TMO Position: Q3 2025 in Review

Galibier Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2025 at 2,432 shares worth $1.18M. The position accounts for 0.39% of the portfolio, ranked #24.

Galibier Capital Management first reported a position in TMO in Q4 2018 and has held it in 28 quarters since. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Galibier Capital Management held 2,432 shares of Thermo Fisher Scientific worth $1.18M as of Q3 2025.
Galibier Capital Management left its Thermo Fisher Scientific share count unchanged in Q3 2025.
Thermo Fisher Scientific made up 0.39% of Galibier Capital Management's portfolio in Q3 2025, its #24 holding.
Galibier Capital Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 28 quarters since.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Galibier Capital Management's 13F filing for Q3 2025, filed 21 Oct 2025.